Vaccine production exists in >55 countries, but many production facili
ties cannot assure a reliable supply of existing or new vaccines. By a
nalysing the characteristics of successful producers, we have identifi
ed seven critical elements for viability, each defined by several indi
cators. Each indicated weakness implies an investment to correct it. T
hirty-one manufacturers were assessed based on these viability indicat
ors and the implied investment costs. Three general groupings were fou
nd. 'Viable' producers scored well in all seven categories. Those with
a 'low probability' of viability are weak in all areas. Facilities re
garded as 'potentially viable' may produce sufficient vaccine to meet
national needs, but must develop appropriate structures to effectively
manage change. This analysis provides a logical system for government
s and donors to evaluate the potential effectiveness of further invest
ment in local vaccine production. (C) 1997 Published by Elsevier Scien
ce Ltd.